Two-stage cytoreductive surgery for ‘extensive’ pseudomyxoma peritonei: A legitimate alternative or salvage strategy?
- 8 August 2024
- journal article
- review article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 50 (10) , 108593
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Survival prediction by Bayesian network modeling for pseudomyxoma peritonei after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapyCancer Medicine, 2022
- Learning Curve of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy – an Analysis of Critical Perioperative and Surgical Outcomes among 155 Peritoneal Surface Malignancy Patients Treated at a Tertiary Care Cancer CentreClinical Oncology, 2022
- History of Peritoneal Surface Malignancy Treatment in JapanIndian Journal of Surgical Oncology, 2019
- Analysis of Clinical Outcomes of Pseudomyxoma Peritonei from Appendicular Origin Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy-A Retrospective Study from INDEPSOIndian Journal of Surgical Oncology, 2019
- Multicentre study of the learning curve and surgical performance of cytoreductive surgery with intraperitoneal chemotherapy for pseudomyxoma peritoneiBritish Journal of Surgery, 2014
- Learning curve for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal surface malignancies: Analysis of two centresJournal of Surgical Oncology, 2012
- Prospective longitudinal study of quality of life following cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritoneiEuropean Journal of Surgical Oncology, 2010
- Impact of the extent and duration of cytoreductive surgery on postoperative hematological toxicity after intraperitoneal chemohyperthermia for peritoneal carcinomatosisJournal of Surgical Oncology, 2005
- Clinically aggressive pseudomyxoma peritonei: A variant of a histologically indolent processJournal of Surgical Oncology, 2004
- Treatment of Primary Peritoneal Mesothelioma by Continuous Hyperthermic Peritoneal Perfusion (CHPP)Annals of Surgical Oncology, 1999